FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Françoise Muller

Research Profile

Physiology

Procedures

Disorders

Anatomy

Amniotic Fluid

Concepts & Ideas

Chemicals & Drugs

Living Beings

Newborn Infant

Co-author Network

Publications

TOP 3
Sophie Dreux; Marc-Antoine Fouré; Françoise Muller; Claire Nguyen; Thomas Schmitz; Elie Azria; Isabelle Czerkiewicz
Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study.
Emmanuel Spaggiari; Anne-Sylvie Valat; Marie Ruas; Thomas Schmitz; Isabelle Czerkiewicz; Anne-Lise Delezoide; Sophie Dreux; Fabien Guimiot; Françoise Muller
Management strategy in pregnancies with elevated second-trimester maternal serum alpha-fetoprotein based on a second assay.
Sophie Dreux; François Goffinet; Françoise Muller; Jean-François Oury; Laurent J Salomon; Loïc Sentilhes
Second-trimester maternal serum markers and placenta accreta.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Françoise Muller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sophie Dreux; Marc-Antoine Fouré; Françoise Muller; Claire Nguyen; Thomas Schmitz; Elie Azria; Isabelle Czerkiewicz
Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study.
American journal of obstetrics and gynecology 2013;208(5):397.e1-5.
2013: Emmanuel Spaggiari; Anne-Sylvie Valat; Marie Ruas; Thomas Schmitz; Isabelle Czerkiewicz; Anne-Lise Delezoide; Sophie Dreux; Fabien Guimiot; Françoise Muller
Management strategy in pregnancies with elevated second-trimester maternal serum alpha-fetoprotein based on a second assay.
American journal of obstetrics and gynecology 2013;208(4):303.e1-7.
2012: Sophie Dreux; François Goffinet; Françoise Muller; Jean-François Oury; Laurent J Salomon; Loïc Sentilhes
Second-trimester maternal serum markers and placenta accreta.
Prenatal diagnosis 2012;32(10):1010-2.
2012: Edouard Lecarpentier; Laurent Mandelbrot; Thomas Blanc; Sophie Dreux; Jean-François Oury; Bruno Schaub; Yves Ville; Alaa El Ghoneimi; Françoise Muller
Biochemical analysis of cystic fluid in the diagnosis of fetal intra-abdominal masses.
Prenatal diagnosis 2012;32(7):627-31.
2012: Sophie Dreux; Ingrid Dugueperoux; Agnès Guichet; Catherine Lepinard; Mathias Boughanim; Alix de Becdelievre; Jean-Marie Rival; Françoise Muller
Relationship of non-visualization of the fetal gallbladder and amniotic fluid digestive enzymes analysis to outcome.
Prenatal diagnosis 2012;32(5):423-6.
2011: Edith Vuillard; Jean-François Oury; Yvon Chitrit; Sophie Dreux; Alaa Elghoneimi; Françoise Muller
Sonographic measurement of corpus spongiosum in male fetuses.
Prenatal diagnosis 2011;31(12):1160-3.
2010: Jean Guibourdenche; Karen Handschuh; Vassilis Tsatsaris; Pascale Gerbaud; M C Leguy; Françoise Muller; D Evain Brion; Thierry Fournier
Hyperglycosylated hCG is a marker of early human trophoblast invasion.
The Journal of clinical endocrinology and metabolism 2010;95(10):E240-4.
2010: Arnaud Garnier; Sophie Dreux; Rosa Vargas-Poussou; Jean-François Oury; alexandra benachi; Georges Deschênes; Françoise Muller
Bartter syndrome prenatal diagnosis based on amniotic fluid biochemical analysis.
Pediatric research 2010;67(3):300-3.
2009: Florine Oca; Sophie Dreux; Bénédicte Gérard; Brigitte Simon-Bouy; Alix de Becdelièvre; Claude Ferec; Emmanuelle Girodon; Françoise Muller
Amniotic fluid digestive enzyme analysis is useful for identifying CFTR gene mutations of unclear significance.
Clinical chemistry 2009;55(12):2214-7.
2008: Aurélie Garchet-Beaudron; Sophie Dreux; Nathalie Leporrier; Jean-François Oury; Françoise Muller
Second-trimester Down syndrome maternal serum marker screening: a prospective study of 11 040 twin pregnancies.
Prenatal diagnosis 2008;28(12):1105-9.
2007: Jean-François Benoist; Apolline Imbard; Sophie Dreux; Catherine Garel; Georges Haddad; Médéric Hoffet; Daniel Biou; Françoise Muller
Antenatal biochemical expression of cystinuria and relation to fetal hyperechogenic colon.
Clinical chemistry 2007;53(1):149-50.
2006: Catherine Garel; Sophie Dreux; Pascale Philippe-Chomette; Edith Vuillard; Jean-François Oury; Françoise Muller
Contribution of fetal magnetic resonance imaging and amniotic fluid digestive enzyme assays to the evaluation of gastrointestinal tract abnormalities.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2006;28(3):282-91.
2006: Julie Gonin; Sophie Dreux; Fabien Guimiot; Françoise Menez; Jean Guibourdenche; Daniel Biou; Françoise Muller
Neural tube defects cannot be diagnosed prenatally by electrophoresis of amniotic fluid transferrin isoforms.
Clinical chemistry 2006;52(8):1618-9.
2006: Sophie Dreux; Thierry Rousseau; Stefan Gerber; Jean-Yves Col; Marc Dommergues; Françoise Muller
Fetal serum beta2-microglobulin as a marker for fetal infectious diseases.
Prenatal diagnosis 2006;26(5):471-4.
2006: Madeleine Azarian; Sophie Dreux; Edith Vuillard; Guerrino Meneguzzi; Saranda Haber; Fabien Guimiot; Françoise Muller
Prenatal diagnosis of inherited epidermolysis bullosa in a patient with no family history: a case report and literature review.
Prenatal diagnosis 2006;26(1):57-9.
2005: Hana Talabani; Sophie Dreux; Dominique Luton; Brigitte Simon-Bouy; Bernard Le Fiblec; Jean-Yves Col; Jean Guibourdenche; Jean-François Oury; Françoise Muller
Fetal anal incontinence evaluated by amniotic fluid digestive enzyme assay in myelomeningocele spina bifida.
Pediatric research 2005;58(4):766-70.
2005: Françoise Muller; Sophie Dreux; Pascal Vaast; Yves Dumez; Israel Nisand; Yves Ville; Pierre Boulot; Jean Guibourdenche; Marc Althusser; Gérard Blin; Evelyne Gautier; Catherine Lespinard; Franck Perrotin; Patrice Poulain; Marie-France Sarramon
Prenatal diagnosis of megacystis-microcolon-intestinal hypoperistalsis syndrome: contribution of amniotic fluid digestive enzyme assay and fetal urinalysis.
Prenatal diagnosis 2005;25(3):203-9.
2004: François Forestier; Corinne Sault; Françoise Muller; P Gaucherand; S Gil; J L Oger
False-positive amniotic fluid acetylcholinesterase PAGE due to contamination by the AFP diluent of an automated instrument.
Prenatal diagnosis 2004;24(6):478-9.
2004: Françoise Muller; Sophie Dreux; François Audibert; Jean-Jacques Chabaud; Thierry Rousseau; Dominique D'Hervé; Yves Dumez; Sandrine Ngo; Marie-Claire Gubler; Marc Dommergues
Fetal serum ss2-microglobulin and cystatin C in the prediction of post-natal renal function in bilateral hypoplasia and hyperechogenic enlarged kidneys.
Prenatal diagnosis 2004;24(5):327-32.
2004: Romain Favre; Sophie Dreux; Marc Dommergues; Yves Dumez; Dominique Luton; Jean-François Oury; Bernard Le Fiblec; Israel Nisand; Françoise Muller
Nonimmune fetal ascites: a series of 79 cases.
American journal of obstetrics and gynecology 2004;190(2):407-12.
2003: Françoise Muller; Sophie Dreux; Alain Lemeur; Corinne Sault; Jean Desgrès; Marguerite-Anne Bernard; Claude Giorgetti; Catherine Lemay; Sophie Mirallié; Alain Beauchet
Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome.
Prenatal diagnosis 2003;23(13):1073-6.
2003: Françoise Muller; Clarisse Benattar; François Audibert; Nathalie Roussel; Sophie Dreux; Howard Cuckle
First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers.
Prenatal diagnosis 2003;23(10):833-6.
2003: Brigitte Simon-Bouy; V Satre; Claude Ferec; Marie-Claire Malinge; Emmanuelle Girodon; E Denamur; N Leporrier; P Lewin; F Forestier; Françoise Muller
Hyperechogenic fetal bowel: a large French collaborative study of 682 cases.
American journal of medical genetics. Part A 2003;121A(3):209-13.
2003: Françoise Muller
Prenatal biochemical screening for neural tube defects.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2003;19(7-8):433-5.
2003: Françoise Muller; Sophie Dreux; Corinne Sault; Armelle Galland; Hugues Puissant; Gisèle Couplet; Catherine Lemay; Marie-Estelle Larcher; Gilles Renom
Very low alpha-fetoprotein in Down syndrome maternal serum screening.
Prenatal diagnosis 2003;23(7):584-7.
2003: Assaad K Kesrouani; Jean Guibourdenche; Françoise Muller; Eric Denamur; Edith Vuillard; Catherine Garel; Anne-Lise Delezoide; Patrice Eydoux; Gérard Tachdjian; Pierre Lebon; Pascal De Lagausie; Olivier Sibony; Clarisse Bauman; Jean-François Oury; Dominique Luton
Etiology and outcome of fetal echogenic bowel. Ten years of experience.
Fetal diagnosis and therapy 2003;18(4):240-6.
2003: Jean-Louis Serre; JOSUE FEINGOLD; Brigitte Simon-Bouy; Françoise Muller
[Towards an improved antenatal screening for cystic fibrosis].
Revue d'épidémiologie et de santé publique 2003;51(2):245-53.
2003: Françoise Muller; Sophie Dreux; Henry Dupoizat; Serge Uzan; Marie-Françoise Dubin; Jean-François Oury; Bernard Dingeon; Marc Dommergues
Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Prenatal diagnosis 2003;23(4):331-5.
2002: Françoise Muller; Didier Thibaud; Françoise Poloce; Marie-Christine Gelineau; Marguerite Bernard; Christine Brochet; Christine Millet; Jean-Yves Réal; Marc Dommergues
Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers.
Prenatal diagnosis 2002;22(11):1036-9.
2002: Françoise Muller; Sophie Dreux; Jean-François Oury; Dominique Luton; Serge Uzan; Michèle Uzan; Michel Levardon; Marc Dommergues
Down syndrome maternal serum marker screening after 18 weeks' gestation.
Prenatal diagnosis 2002;22(11):1001-4.
2002: Françoise Muller; François Forestier; Bernard Dingeon
Second trimester trisomy 21 maternal serum marker screening. Results of a countrywide study of 854,902 patients.
Prenatal diagnosis 2002;22(10):925-9.
2002: Françoise Muller; Corinne Sault; Catherine Lemay; Nathalie Roussel-Mizon; François Forestier; Jean-Louis Frendo
Second trimester two-step trisomy 18 screening using maternal serum markers.
Prenatal diagnosis 2002;22(7):605-8.
2002: Françoise Muller; Brigitte Simon-Bouy; Emmanuelle Girodon; Nicole Monnier; Marie-Claire Malinge; Jean-Louis Serre
Predicting the risk of cystic fibrosis with abnormal ultrasound signs of fetal bowel: results of a French molecular collaborative study based on 641 prospective cases.
American journal of medical genetics 2002;110(2):109-15.
2002: Brigitte Simon-Bouy; Françoise Muller
Hyperechogenic fetal bowel and Down syndrome. Results of a French collaborative study based on 680 prospective cases.
Prenatal diagnosis 2002;22(3):189-92.
2001: Anne-Sophie Lia-Baldini; Françoise Muller; Agnès Taillandier; JF Gibrat; M Mouchard; B Robin; Brigitte Simon-Bouy; Jean-Louis Serre; Arthur S Aylsworth; E Bieth; S Delanote; Peter Freisinger; J C Hu; H P Krohn; M E Nunes; Etienne Mornet
A molecular approach to dominance in hypophosphatasia.
Human genetics 2001;109(1):99-108.
2001: Agnès Taillandier; Anne-Sophie Lia-Baldini; M Mouchard; B Robin; Françoise Muller; Brigitte Simon-Bouy; Jean-Louis Serre; A Bera-Louville; M Bonduelle; J Eckhardt; D Gaillard; A G Myhre; S Körtge-Jung; L Larget-Piet; E Malou; D Sillence; I K Temple; Géraldine Viot; Etienne Mornet
Twelve novel mutations in the tissue-nonspecific alkaline phosphatase gene (ALPL) in patients with various forms of hypophosphatasia.
Human mutation 2001;18(1):83-4.
2000: Françoise Muller; M Rebiffé; Agnès Taillandier; J F Oury; Etienne Mornet
Parental origin of the extra chromosome in prenatally diagnosed fetal trisomy 21.
Human genetics 2000;106(3):340-4.
2000: Agnès Taillandier; E Cozien; Françoise Muller; Y Merrien; E Bonnin; C Fribourg; Brigitte Simon-Bouy; Jean-Louis Serre; E Bieth; R Brenner; M P Cordier; S De Bie; Florence Fellmann; Peter Freisinger; V Hesse; Raoul Hennekam; D Josifova; L Kerzin-Storrar; N Leporrier; M T Zabot; Etienne Mornet
Fifteen new mutations (-195C>T, L-12X, 298-2A>G, T117N, A159T, R229S, 997+2T>A, E274X, A331T, H364R, D389G, 1256delC, R433H, N461I, C472S) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in patients with hypophosphatasia.
Human mutation 2000;15(3):293.
1999: Françoise Muller; M A Bernard; A Benkirane; S Ngo; stephen lortat-jacob; J F Oury; M Dommergues
Fetal urine cystatin C as a predictor of postnatal renal function in bilateral uropathies.
Clinical chemistry 1999;45(12):2292-3.
1999: Françoise Muller; S Ngo; M Rebiffé; J F Oury; S Uzan; D Satgé
Maternal serum s100b protein is ineffective for Down syndrome screening.
Prenatal diagnosis 1999;19(11):1086.
1999: Etienne Mornet; Françoise Muller; S Ngo; Agnès Taillandier; Brigitte Simon-Bouy; I Maire; J F Oury
Correlation of alkaline phosphatase (ALP) determination and analysis of the tissue non-specific ALP gene in prenatal diagnosis of severe hypophosphatasia.
Prenatal diagnosis 1999;19(8):755-7.
1999: Françoise Muller; Philippe AEGERTER; S Ngo; A Fort; Alain Beauchet; P Giraudet; M Dommergues
Software for prenatal down syndrome risk calculation: a comparative study of six software packages.
Clinical chemistry 1999;45(8 Pt 1):1278-80.
1999: L Zurutuza; Françoise Muller; JF Gibrat; Agnès Taillandier; Brigitte Simon-Bouy; Jean-Louis Serre; Etienne Mornet
Correlations of genotype and phenotype in hypophosphatasia.
Human molecular genetics 1999;8(6):1039-46.
1999: Agnès Taillandier; L Zurutuza; Françoise Muller; Brigitte Simon-Bouy; Jean-Louis Serre; L Bird; R Brenner; Odile Boute; J Cousin; D Gaillard; P H Heidemann; B Steinmann; M Wallot; Etienne Mornet
Characterization of eleven novel mutations (M45L, R119H, 544delG, G145V, H154Y, C184Y, D289V, 862+5A, 1172delC, R411X, E459K) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in patients with severe hypophosphatasia. Mutations in brief no. 217. Online.
Human mutation 1999;13(2):171-2.
1999: Françoise Muller; Christophe Doche; S Ngo; S Faïna; M A Charvin; M Rebiffé; V Taguel; Bernard Dingeon
Stability of free beta-subunit in routine practice for trisomy 21 maternal serum screening.
Prenatal diagnosis 1999;19(1):85-6.
1998: Françoise Muller; S Ngo; Philippe AEGERTER; S Le Bourdellès; V Taguel; M Rebiffé; S Faïna; P Giraudet
Evaluation of the Abbott system in maternal serum screening for Down syndrome: the AxSym analyzer, AFP and hCG reagents and Maciel Prenatal Interpretive Software.
Clinica chimica acta; international journal of clinical chemistry 1998;277(1):65-75.
1998: Françoise Muller; M Dommergues; Brigitte Simon-Bouy; Claude Ferec; J F Oury; M C Aubry; R Bessis; Edith Vuillard; E Denamur; T Bienvenu; Jean-Louis Serre
Cystic fibrosis screening: a fetus with hyperechogenic bowel may be the index case.
Journal of medical genetics 1998;35(8):657-60.
1998: Etienne Mornet; Agnès Taillandier; S Peyramaure; F Kaper; Françoise Muller; R Brenner; P Bussière; Peter Freisinger; J Godard; M Le Merrer; J F Oury; H Plauchu; R Puddu; J M Rival; andrea superti-furga; Renaud Touraine; Jean-Louis Serre; Brigitte Simon-Bouy
Identification of fifteen novel mutations in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in European patients with severe hypophosphatasia.
European journal of human genetics : EJHG 1998;6(4):308-14.
1997: Bernard Dingeon; Christophe Doche; L Doche; J C Eynard; S Mercier; Françoise Muller
[For a new approach of comprehensive quality control in clinical biology. Application to prenatal markers of trisomy risks].
Annales de biologie clinique 1997;55(6):637-8.
1997: Etienne Mornet; Françoise Muller; A Lenvoisé-Furet; A L Delezoide; Jean-Yves Col; Brigitte Simon-Bouy; Jean-Louis Serre
Screening of the C677T mutation on the methylenetetrahydrofolate reductase gene in French patients with neural tube defects.
Human genetics 1997;100(5-6):512-4.
1996: Françoise Muller; M Dommergues; L Bussières; Philippe AEGERTER; B Le Fiblec; S Uzan; J F Oury; J C Colau; Y Dumez
Prenatal screening for Down syndrome: should first trimester ultrasound replace maternal serum screening?
Early human development 1996;47 Suppl():S37-9.
1996: L Savey; Françoise Muller; G Ndayizamba; B Lefiblec; B Serra; J C Colau
[Maternal serum hCG at 15 weeks. Its value for detecting risk of pre-eclampsia or fetal hypotrophy].
Presse médicale (Paris, France : 1983) 1996;25(40):2049.
1996: Françoise Muller; M Dommergues; L Bussières; stephen lortat-jacob; C Loirat; J F Oury; Y Aigrain; P Niaudet; Philippe AEGERTER; Yves Dumez
Development of human renal function: reference intervals for 10 biochemical markers in fetal urine.
Clinical chemistry 1996;42(11):1855-60.
1996: Françoise Muller; L Savey; B Le Fiblec; L Bussières; G Ndayizamba; J C Colau; P Giraudet
Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia.
American journal of obstetrics and gynecology 1996;175(1):37-40.
1996: Françoise Muller; L Bussières
Maternal serum markers for fetal trisomy 21 screening.
European journal of obstetrics, gynecology, and reproductive biology 1996;65(1):3-6.
1995: Françoise Muller; L Bussières; B Chevallier
[Maternal serum markers of fetal trisomy 21].
Presse médicale (Paris, France : 1983) 1995;24(27):1265-9.
1995: Françoise Muller; M Dommergues; M C Aubry; Brigitte Simon-Bouy; E Gautier; J F Oury; F Narcy
Hyperechogenic fetal bowel: an ultrasonographic marker for adverse fetal and neonatal outcome.
American journal of obstetrics and gynecology 1995;173(2):508-13.
1994: Françoise Muller; M Dommergues; Y Ville; Fanny Lewin; N Delvalez-Morichon; C Nihoul-Fekete; Frédéric Bargy; Yves Dumez; A Boue
Amniotic fluid digestive enzymes: diagnostic value in fetal gastrointestinal obstructions.
Prenatal diagnosis 1994;14(10):973-9.
1994: Françoise Muller; L Bussières; M C Pèlissier; J F Oury; C Boué; S Uzan; A Boué
Do racial differences exist in second-trimester maternal hCG levels? A study of 23,369 patients.
Prenatal diagnosis 1994;14(7):633-6.
1994: E Decoret; Olivier Sibony; Edith Vuillard; Antoine Bedu; O Faure; Laurent Mandelbrot; Françoise Muller; Jean-François Oury; Philippe Blot
Prenatal diagnosis of in utero fetal gastrointestinal bleeding.
Fetal diagnosis and therapy 1994;9(4):252-5.
1994: Françoise Muller; P Parvy; M Dommergues; stephen lortat-jacob; Yves Dumez; P Kamoun
[Free amino acids in fetal urine and prognosis of renal function in bilateral obstructive uropathies].
Annales de biologie clinique 1994;52(9):651-5.
1993: Françoise Muller; M Dommergues; Laurent Mandelbrot; M C Aubry; C Nihoul-Fekete; Yves Dumez
Fetal urinary biochemistry predicts postnatal renal function in children with bilateral obstructive uropathies.
Obstetrics and gynecology 1993;82(5):813-20.
1993: F Duchatel; Françoise Muller; J F Oury; B Mennesson; J Boue; A Boue
Prenatal diagnosis of cystic fibrosis: ultrasonography of the gallbladder at 17-19 weeks of gestation.
Fetal diagnosis and therapy 1993;8(1):28-36.
1992: Françoise Muller; Brigitte Simon-Bouy; M C Aubry; F Duchatel; R Bessis; J Boué
[Accidental ultrasonographic disclosure of isolated intra-abdominal fetal hyperechogenicity. Apropos of a series of 87 cases].
Journal de radiologie 1992;73(12):699-704.
1991: Françoise Muller; J F Oury; P Bussière; Fanny Lewin; J Boué
First-trimester diagnosis of hypophosphatasia. Importance of gestational age and purity of CV samples.
Prenatal diagnosis 1991;11(9):725-30.
1991: Françoise Muller; Brigitte Simon-Bouy; M C Aubry; F Duchatel; R Bessis; J Boué
[Fortuitous discovery in echography of an isolated fetal intra-abdominal hyperechogenic mass. 87 cases].
Journal de gynécologie, obstétrique et biologie de la reproduction 1991;20(8):1115-21.
1990: Françoise Muller; A Boué
A single chorionic gonadotropin assay for maternal serum screening for Down's syndrome.
Prenatal diagnosis 1990;10(6):389-98.
1990: Françoise Muller; G Pantin; N Normand; D Bucheton; H Der Sarkissian; J Boué; P Giraudet; R Henrion; A Boué
[Does systemic determination of maternal serum alpha-1-fetoprotein have any value?].
Archives françaises de pédiatrie 1990;47(6):473-4.
1990: stephen lortat-jacob; C N Fekete; Yves Dumez; Françoise Muller; M C Aubry; J P Aubry
[Prenatal diagnosis and neonatal management of posterior urethral valves: apropos of 33 case reports].
Acta urologica Belgica 1990;58(1):29-37.
1990: Yves Dumez; Françoise Muller; M Dommergues; C Nihoul-Fekete
[Antenatal diagnosis of obstructive uropathies].
Chirurgie; mémoires de l'Académie de chirurgie 1990;116(6-7):517-22.
1989: Françoise Muller; J F Oury; A Boue
First-trimester amniotic fluid acetylcholinesterase electrophoresis.
Prenatal diagnosis 1989;9(3):173-5.
1989: Etienne Mornet; Brigitte Simon-Bouy; Jean-Louis Serre; Françoise Muller; Agnès Taillandier; M Martinez; J Boue; A Boue
Genetic heterogeneity between two clinical forms of cystic fibrosis evidenced by familial analysis and linked DNA probes.
Clinical genetics 1989;35(2):81-7.
1988: A Boue; Françoise Muller; M L Briard; J Boue
Interest of biology in the management of pregnancies where a fetal malformation has been detected by ultrasonography.
Fetal therapy 1988;3(1-2):14-23.
1986: A Boué; Françoise Muller; C Nezelof; J F Oury; F Duchatel; Yves Dumez; M C Aubry; J Boué
Prenatal diagnosis in 200 pregnancies with a 1-in-4 risk of cystic fibrosis.
Human genetics 1986;74(3):288-97.
1986: Françoise Muller; M Rebiffé; H Der Sarkissian; J Boué; A Boué
[Decrease of various enzyme activities in the amniotic fluid of the fetuses with chromosomal anomalies].
Annales de génétique 1986;29(1):27-31.
1985: Françoise Muller; M C Aubry; B Gasser; F Duchatel; J Boué; A Boué
Prenatal diagnosis of cystic fibrosis. II. Meconium ileus in affected fetuses.
Prenatal diagnosis 1985;5(2):109-17.
1984: Françoise Muller; J C Frot; M C Aubry; J Boue; A Boue
Meconium ileus in cystic fibrosis fetuses.
Lancet 1984;2(8396):223.